Research location
Focşani
Romania
Advertisement
Research activity in Focşani
RomaniaCureCurrent currently publishes aggregate city-level research activity for this location: 24 trials and 26 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Focşani
24 linked trials · page 1 of 1Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia SymptomsNCT06559306 · 2024-07-25 · 1 site observation
RECRUITING
A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Major Depressive Disorder Who Experience a Loss of Interest and PleasureNCT06635135 · 2024-09-19 · 1 site observation
TERMINATED
A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat® InhalerNCT03663569 · 2018-08-15 · 1 site observation
COMPLETED
Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD)NCT03034967 · 2017-04-25 · 1 site observation
COMPLETED
AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.NCT02511106 · 2015-10-21 · 1 site observation
ACTIVE_NOT_RECRUITING
A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary DiseaseNCT02207829 · 2014-09-01 · 1 site observation
COMPLETED
Global Non-interventional Heart Failure Disease RegistryNCT02595814 · 2014-07-23 · 1 site observation
TERMINATED
Efficacy and Safety of Mepolizumab as an Add-on Treatment in Chronic Obstructive Pulmonary Disease (COPD)NCT02105961 · 2014-04-24 · 1 site observation
COMPLETED
A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge PatientsNCT02111564 · 2014-01-07 · 1 site observation
COMPLETED
A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart FailureNCT01877915 · 2013-09-10 · 1 site observation
COMPLETED
A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol With Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT01879410 · 2013-06-13 · 1 site observation
COMPLETED
Lurasidone Low-Dose - High-Dose Study StudyNCT01821378 · 2013-05-01 · 1 site observation
COMPLETED
Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.NCT01813721 · 2012-12-01 · 1 site observation
COMPLETED
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With SchizophreniaNCT01668797 · 2012-10-01 · 1 site observation
COMPLETED
CorRELation Between PatIent PErception and Findings on Clinical ExaminationNCT01627743 · 2012-07-01 · 1 site observation
COMPLETED
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With SchizophreniaNCT01412060 · 2011-09-27 · 1 site observation
COMPLETED
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With SchizophreniaNCT01397786 · 2011-09-01 · 1 site observation
COMPLETED
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute SchizophreniaNCT01396421 · 2011-07-01 · 1 site observation
COMPLETED
A Study in Prevention of Re-emergence of Depression SymptomsNCT01299272 · 2011-05-01 · 1 site observation
COMPLETED
Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate CancerNCT01308580 · 2011-04-01 · 1 site observation
COMPLETED
A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder.NCT01197508 · 2010-09-01 · 1 site observation
COMPLETED
Assessment of the Safety and Efficacy of Pramipexole Extended Release in Patients With Parkinson's Disease in Routine Clinical PracticeNCT01061567 · 2009-11-01 · 2 site observations
COMPLETED
Effects of Tinzaparin on Cardio-vascular Outcomes and on Blood Lipids in Diabetic Patients on Chronic HemodialysisNCT00407641 · 2009-03-01 · 1 site observation
WITHDRAWN
Kinetic Tremor in Parkinsons Disease: Its Course Under Pramipexole (Mirapexin®) Treatment and Impact on Quality of LifeNCT01100073 · 2008-02-01 · 2 site observations
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.